Table 1.

Increase of the hazard with every increase of dimensional triglyceride levels by 89 mg/dL and 1 SD in both fasting and non-fasting men and women.

Gender	Analyses	Increase of triglyceride level by 89 mg/dL			Increase of triglyceride level by 1 SD
		HR	95% CI	p-Value	HR	95% CI	p-Value
		Fasting women	Adjustment 1†	1.2	1.1–1.4	0.001	1.3	1.1–1.6	0.001
	Adjustment 2‡	1.2	1.1–1.4	0.002	1.3	1.1–1.6	0.002
	Adjustment 3¶	1.1	1.0–1.3	0.162	1.2	0.9–1.5	0.162
Fasting men	Adjustment 1†	1.0	0.8–1.1	0.574	0.9	0.7–1.2	0.574
	Adjustment 2‡	1.0	0.9–1.2	0.869	1.0	0.8–1.2	0.869
	Adjustment 3¶	1.0	0.8–1.2	0.722	0.9	0.7–1.3	0.722
Non-fasting women	Adjustment 1†	1.0	0.7–1.2	0.779	0.9	0.6–1.4	0.779
	Adjustment 2‡	0.9	0.6–1.2	0.403	0.8	0.5–1.4	0.403
	Adjustment 3¶	0.7	0.5–1.1	0.137	0.6	0.3–1.2	0.137
Non-fasting men	Adjustment 1†	0.9	0.7–1.1	0.269	0.8	0.6–1.2	0.269
	Adjustment 2‡	0.9	0.7–1.2	0.625	0.9	0.6–1.3	0.625
	Adjustment 3¶	0.8	0.5–1.2	0.307	0.7	0.3–1.4	0.307

CI, confidence interval; HR, hazard ratio estimated by Cox proportional hazard model.

^†Crude, ^‡age, ^¶fasting women: age, cholesterol, lipid lowering therapy, HDL; fasting men: age, cholesterol, HDL, diabetes; non-fasting women: age, cholesterol, HDL, diabetes, BMI; non-fasting men: age, cholesterol, lipid lowering therapy, diabetes, hypertension, BMI.

Bold print indicates that the p-value for the corresponding HR is < 0.05.